When does atherosclerosis become irreversible? Chronological change from an early to an advanced atherosclerotic lesion observed by angioscopy

Angiology

Volumn 56, Issue 4, 2005, Pages 361-370

  Ikeda, Norimichi ^a,b,c   Torii, Ryuzou ^a,c  

^a Ohtsu Municipal Hospital ^*

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c Shiga University of Medical Science   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; ICOSAPENTAENOIC ACID;

ANGIOSCOPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DISEASE COURSE; MACACA; NONHUMAN; SMOOTH MUSCLE FIBER;

ANGIOSCOPY; ANIMALS; ARTERIOSCLEROSIS; BALLOON DILATATION; CHOLESTEROL; DISEASE PROGRESSION; EICOSAPENTAENOIC ACID; MACACA;

EID: 22844434694     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970505600401     Document Type: Article

References (23)

1. Faggiotto A, Ross R, Harker L: Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4:323-340, 1984.
2. Parks JS, Rudel LL: Effect of fish oil on atherosclerosis and lipoprotein metabolism. Atherosclerosis 84: 83-94, 1990.
3. Wissler RW, Vesselinovitch D: Can atherosclerotic plaques regress? Anatomic and biochemical evidence from nonhuman animal models. Am J Cardiol 65:33F-40F, 1990.
4. Sasahara M, Raines EW, Chait A, et al: Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probukol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation? J Clin Invest 94:155-164, 1994.
5. Dewailly E, Blanche C, Lemieu S, et al: n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr 74:464-473, 2001.
6. Ikeda N, Torii R: Angioscopic evaluation of the effect of estrogen on ovariectomized Japanese monkeys. Ann NY Acad Sci 947:424-428, 2001.
7. Torii R, Shiomi M, Ikeda N, et al: Cholesterol-fed ovariectomized monkeys are good animal models for human atherosclerosis of postmenopausal women. Primates 44:247-252, 2003.
8. den Heijer P, Foley DP, Escaned J, et al: Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus. J Am Coll Cardiol 24: 649-654, 1994.
9. Feld S, Ganim M, Carell ES, et al: Comparison of angioscopy, intravascular ultrasound imaging and quantitative coronary angiography in predicting clinical outcome after coronary intervention in high-risk patients. J Am Coll Cardiol 28:97-105, 1996.
10. Stary HC: Composition and classification of human atherosclerotic lesions. Virchows Arch A Pathol Anat Histopathol 421:277-290, 1992.
11. Stary HC, Chandler AB, Dinsmore RE, et al: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol 15:1512-1531, 1995.
12. Guyton JR, Klemp KF: Development of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. Arterioscler Thromb 14:1305-1314, 1994.
13. Pearson TA, Dillman JM, Solez K, et al: Evidence for two populations of fatty streaks with different roles in the atherogenic process. Lancet 2:496-498, 1980.
14. MAAS investigators: Effect of simvastatin on coronary atheroma: The Multicentre Anti-Atheroma Study (MAAS). Lancet 344:633-638, 1994.
15. Jukema JW, Bruschke AV, van Boven AJ, et al: Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: The Regression Growth Evaluation Staun Study (REGRESS). Circulation 91:2528-2540, 1995.
16. Jarvinen O, Laurikka J, Sisto T, et al: Atherosclerosis of the visceral arteries. Vasa 24:9-14, 1995.
17. Ross R, Glomset JA: Atherosclerosis and arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 180:1332-1339, 1973.
18. Ross R, Glomset J, Harker L: Response to injury and atherogenesis. Am J Pathol 86:675-684, 1977.
19. Sata M, Saiura A, Kunisato A, et al: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8:403-409, 2002.
20. de Faire U, Ericsson CG, Grip L, et al: Retardation of coronary atherosclerosis: The Bezafibrate Coronary Atherosclerosis Trial (BECAIT) and other angiographic trials. Cardiovasc Drugs Ther 11(suppl 1): 257-263, 1997.
21. Mizutani M, Asano M, Soma M, et al: Omega-3 polyunsaturated fatty acids inhibit migration of human vascular smooth muscle cells in vitro. Life Sci 61:PL269-PL274, 1997.
22. Pakala R, Pakala R, Sheng WL, et al: Vascular smooth muscle cells preloaded with eicosapentaenoic acid and docosahexaenoic acid fail to respond to serotonin stimulation. Atherosclerosis 153:47-57, 2000.
23. Terano T, Tanaka T, Tamura Y, et al: Eicosapentaenoic acid and docosahexaenoic acid inhibit vascular smooth muscle cell proliferation by inhibiting phosphorylation of Cdk2-cyclinE complex. Biochem Biophys Res Commun 254:502-506, 1999.